Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 95 articles:
HTML format



Single Articles


    February 2024

  1. Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8.
    Obstet Gynecol. 2024;143:e31-e39.
    PubMed     Abstract available


    January 2024
  2. BAUERFEIND A, von Stockum S, Boehnke T, Heinemann K, et al
    Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Obstet Gynecol. 2024 Jan 16. doi: 10.1097/AOG.0000000000005509.
    PubMed     Abstract available


  3. KRASHIN JW, Black P, Brannen E, Gard CC, et al
    Geographic Access to Early Pregnancy Loss Management.
    Obstet Gynecol. 2024 Jan 11. doi: 10.1097/AOG.0000000000005505.
    PubMed     Abstract available



  4. ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression: Correction.
    Obstet Gynecol. 2024;143:e20.
    PubMed    


    December 2023
  5. IZATT A, Greenberg RA, Thorne J, Erdman J, et al
    Ethical and Legal Considerations for Sterilization Refusal in Nulliparous Women.
    Obstet Gynecol. 2023;142:1316-1321.
    PubMed     Abstract available


  6. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    PubMed     Abstract available


    November 2023
  7. RAMANADHAN S, Jensen J
    The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
    Obstet Gynecol. 2023 Nov 21. doi: 10.1097/AOG.0000000000005466.
    PubMed     Abstract available


  8. ALLEN RH, Bartz D
    Opill: The Over-the-Counter Contraceptive Pill.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005455.
    PubMed     Abstract available


  9. EBERLE A, Nguyen DB, Smith JP, Mansour FW, et al
    Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005444.
    PubMed     Abstract available


    October 2023
  10. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005421.
    PubMed     Abstract available


  11. HENKEL A, Miller HE, Zhang J, Lyell DJ, et al
    Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005259.
    PubMed     Abstract available



  12. Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.
    PubMed    


    September 2023
  13. BULLINGTON BW, Berg KA, Miller ES, Boozer M, et al
    Association Among Race, Ethnicity, Insurance Type, and Postpartum Permanent Contraception Fulfillment.
    Obstet Gynecol. 2023 Sep 7. doi: 10.1097/AOG.0000000000005328.
    PubMed     Abstract available


    August 2023
  14. DARNEY BG, Biel FM, Oakley J, Coleman-Minahan K, et al
    Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005277.
    PubMed     Abstract available


  15. FASSETT MJ, Reed SD, Rothman KJ, Pisa F, et al
    Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005299.
    PubMed     Abstract available


    July 2023
  16. MOSESON H, Jayaweera R, Egwuatu I, Grosso B, et al
    Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005266.
    PubMed     Abstract available



  17. Medicaid and Fulfillment of Postpartum Permanent Contraception Requests: Correction.
    Obstet Gynecol. 2023;142:221-222.
    PubMed    



  18. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5: Correction.
    Obstet Gynecol. 2023;142:221.
    PubMed    


    May 2023
  19. VALERIE F
    Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
    Obstet Gynecol. 2023 May 24. doi: 10.1097/AOG.0000000000005253.
    PubMed    


  20. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    PubMed     Abstract available


  21. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    PubMed     Abstract available


  22. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    PubMed     Abstract available


    April 2023
  23. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    PubMed     Abstract available


  24. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    PubMed     Abstract available


  25. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    PubMed     Abstract available


  26. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    PubMed     Abstract available


  27. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    PubMed     Abstract available



  28. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    PubMed     Abstract available


    March 2023
  29. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    PubMed     Abstract available


    February 2023
  30. MADISON AM, Powers D, Maslowsky J, Goyal V, et al
    Association Between Publicly Funded Contraceptive Services and the Abortion Rate in Texas, 2010-2015.
    Obstet Gynecol. 2023;141:361-370.
    PubMed     Abstract available


    January 2023
  31. PEARLMAN SHAPIRO M, Dethier D, Kahili-Heede M, Kaneshiro B, et al
    No-Test Medication Abortion: A Systematic Review.
    Obstet Gynecol. 2023;141:23-34.
    PubMed     Abstract available


    December 2022
  32. WU J, Trahair E, Happ M, Swartz J, et al
    TikTok, #IUD, and User Experience With Intrauterine Devices Reported on Social Media.
    Obstet Gynecol. 2022 Dec 6. doi: 10.1097/AOG.0000000000005027.
    PubMed     Abstract available


    November 2022
  33. UWANAKA O, Qureshey E, Wagner SM, Gupta M, et al
    Temporal Changes in Counseling for and Use of Emergency Contraception.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00611.
    PubMed     Abstract available


  34. ANTHONY MS, Zhou X, Schoendorf J, Reed SD, et al
    Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00606.
    PubMed     Abstract available


    October 2022
  35. BAKER CC, Creinin MD
    Long-Acting Reversible Contraception.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00599.
    PubMed     Abstract available


  36. COLEMAN-MINAHAN K, Boniface ER, Fuentes-Rivera E, Saavedra-Avendano B, et al
    Patterns in Contraceptive Use Among Women of Mexican Origin in the United States and in Mexico.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00582.
    PubMed     Abstract available


  37. ROMANSKI PA, Gelvin B, Bortoletto P, Rosenwaks Z, et al
    Live-Birth Outcomes Among Women With Infertility and Anti-Mullerian Hormone Levels of 0.3 ng/mL or Lower.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00590.
    PubMed     Abstract available


  38. PANKO TL
    Reproductive Justice for the Deaf Community.
    Obstet Gynecol. 2022;140:560-564.
    PubMed     Abstract available


    September 2022

  39. General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.
    Obstet Gynecol. 2022;140:528-541.
    PubMed     Abstract available


  40. CIRUCCI C, Harrison D, Francis C
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;140:519.
    PubMed    


  41. COCKRUM RH, Soo J, Ham SA, Cohen KS, et al
    Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
    Obstet Gynecol. 2022;140:477-487.
    PubMed     Abstract available


    August 2022
  42. ELGEMARK K, Graner S, McTaggart J, Ramirez Lofstrom J, et al
    The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
    Obstet Gynecol. 2022;140:227-233.
    PubMed     Abstract available


    July 2022
  43. MARTINEZ OP, Wilder L, Seal P
    Ultrasound-Guided Compared With Non-Ultrasound-Guided Placement of Immediate Postpartum Intrauterine Contraceptive Devices.
    Obstet Gynecol. 2022;140:91-93.
    PubMed     Abstract available


  44. EDELMAN AB, Hennebold JD, Bond K, Lim JY, et al
    Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;140:48-54.
    PubMed     Abstract available


    June 2022
  45. ROE AH, Abernathy A, Flynn AN, McAllister A, et al
    Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
    Obstet Gynecol. 2022;139:1149-1151.
    PubMed     Abstract available


  46. BIGGS MA, Ehrenreich K, Morris N, Blanchard K, et al
    Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
    Obstet Gynecol. 2022;139:1111-1122.
    PubMed     Abstract available


    May 2022
  47. PAKEY J, Nassim JS, Reynolds RV
    Hormonal Intrauterine Devices and Acne.
    Obstet Gynecol. 2022;139:919-921.
    PubMed    


  48. PETERSON SF, Lerma K, Shaw KA, Blumenthal PD, et al
    Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions.
    Obstet Gynecol. 2022;139:907-909.
    PubMed    


  49. HARMON QE, Patchel SA, Zhao S, Umbach DM, et al
    Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Obstet Gynecol. 2022;139:797-807.
    PubMed     Abstract available


  50. RODRIGUEZ MI, Manibusan B, Kaufman M, McConnell KJ, et al
    Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
    Obstet Gynecol. 2022;139:781-787.
    PubMed     Abstract available


  51. GOLDBERG AB, Fulcher IR, Fortin J, Hofer RK, et al
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;139:771-780.
    PubMed     Abstract available


  52. KOPP-KALLNER H, Linder M, Cesta CE, Segovia Chacon S, et al
    Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
    Obstet Gynecol. 2022;139:764-770.
    PubMed     Abstract available


    April 2022
  53. LAZORWITZ A, Pena M, Sheeder J, Teal S, et al
    Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2022;139:579-587.
    PubMed     Abstract available


  54. QURESHEY EJ, Chauhan SP, Wagner SM, Batiste O, et al
    Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;139:571-578.
    PubMed     Abstract available


    March 2022
  55. BRANT AR, Batur P, Arrigain S, Lopez R, et al
    Out-of-Pocket Expenditures for Contraceptives During State Medicaid Expansion, 2013-2016.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00411.
    PubMed    


  56. BURGER T, Li J, Zhao Q, Schreiber CA, et al
    Association of Obesity With Longer Time to Pregnancy.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00400.
    PubMed     Abstract available


  57. GARIEPY AM, Lewis C, Zuckerman D, Tancredi DJ, et al
    Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.
    Obstet Gynecol. 2022;139:423-432.
    PubMed     Abstract available


  58. DANVERS AA, Evans TA
    Risk of Sterilization Regret and Age: An Analysis of the National Survey of Family Growth, 2015-2019.
    Obstet Gynecol. 2022;139:433-439.
    PubMed     Abstract available


    February 2022
  59. STEENLAND MW, Rodriguez MI, Cohen JL
    Changes in the Supply Duration of Combined Oral Contraception During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2022 Feb 3. pii: 00006250-990000000-00386.
    PubMed    



  60. Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1.
    Obstet Gynecol. 2022;139:350-353.
    PubMed    


    November 2021
  61. MAGNUSSON BM, Christensen SR, Tanner AB, Eyring JB, et al
    Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00334.
    PubMed     Abstract available


    October 2021
  62. BRANT AR, Kollikonda S, Yao M, Mei L, et al
    Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Obstet Gynecol. 2021 Oct 7. pii: 00006250-990000000-00308.
    PubMed     Abstract available


  63. BURLANDO AM, Flynn AN, Gutman S, McAllister A, et al
    The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2021;138:574-577.
    PubMed     Abstract available


  64. BOUMA-JOHNSTON H, Arora KS
    Website Review of Variation in Individual State Medicaid Sterilization Policies.
    Obstet Gynecol. 2021;138:578-579.
    PubMed    


  65. BOHN JA, Bullard KA, Rodriguez MI, Ecker AM, et al
    Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2021;138:557-564.
    PubMed     Abstract available


    August 2021
  66. WU JP, Zhang J, McKee M, Akobirshoev I, et al
    Contraceptive Provision and Quality Care Measures for Insured Individuals in Massachusetts Who Are Deaf or Hard of Hearing.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00251.
    PubMed     Abstract available


  67. SCHAUB AM, Pisarska MD, Wright KN
    Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00258.
    PubMed     Abstract available



  68. Access to Postabortion Contraception: ACOG Committee Opinion, Number 833.
    Obstet Gynecol. 2021;138:e91-e95.
    PubMed     Abstract available



  69. Access to Postabortion Contraception: ACOG Committee Opinion Summary, Number 833.
    Obstet Gynecol. 2021;138:324-325.
    PubMed     Abstract available


    July 2021
  70. BAKENRA A, Gero A, Sanders J, Simmons R, et al
    Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    Obstet Gynecol. 2021;138:79-84.
    PubMed     Abstract available


  71. ARORA KS, Ponsaran R, Morello L, Katabi L, et al
    Obstetrician-Gynecologists' Practices in Postpartum Sterilization Without a Valid Medicaid Consent Form.
    Obstet Gynecol. 2021;138:66-72.
    PubMed     Abstract available


    June 2021

  72. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol. 2021;137:e100-e115.
    PubMed     Abstract available



  73. Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.
    Obstet Gynecol. 2021;137:e169-e176.
    PubMed     Abstract available


    May 2021
  74. HAMDAOUI N, Cardinale C, Fabre C, Baumstarck K, et al
    Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00191.
    PubMed     Abstract available


    April 2021
  75. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    PubMed     Abstract available


  76. ALLANSON ER, Copson S, Spilsbury K, Criddle S, et al
    Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00158.
    PubMed     Abstract available


  77. COHEN M, Edelman A, Bellussi F, Berghella V, et al
    Cochrane Review Summaries-April 2021.
    Obstet Gynecol. 2021;137:747-749.
    PubMed     Abstract available


    March 2021
  78. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    PubMed     Abstract available


  79. BORAAS CM, Sanders JN, Schwarz EB, Thompson I, et al
    Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00136.
    PubMed    



  80. Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
    Obstet Gynecol. 2021;137:e75-e88.
    PubMed     Abstract available


    February 2021
  81. AKTURK HK
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    PubMed     Abstract available


  82. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.
    PubMed    


    January 2021

  83. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    PubMed     Abstract available


    December 2020
  84. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    PubMed     Abstract available


    November 2020

  85. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    PubMed     Abstract available



  86. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    PubMed     Abstract available


    October 2020
  87. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    PubMed     Abstract available



  88. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    PubMed     Abstract available


    September 2020
  89. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    PubMed     Abstract available


    August 2020
  90. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    PubMed     Abstract available


  91. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    PubMed     Abstract available


    June 2020
  92. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.
    PubMed    


  93. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.
    PubMed    


  94. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    PubMed     Abstract available


  95. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.